PATENT CLAIM ANALYSIS

Application Number: 15749416
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["506", "010000"]

Abstract:
A method of characterizing a glioblastoma multiforme (GBM) stem cell (GSC), comprising culturing the GSC to provide a culture, contacting a first set of aliquots of the culture with individual compounds selected from a panel of compounds, identifying two or more of the selected compounds that cause more than a threshold level of cell death in the first set of aliquots, and characterizing the GSC as suitable for treatment with one or more combinations comprising the two or more identified compounds. A panel of anti-GBM chemotherapeutic compounds, the compounds selected by a method comprising surgically resecting the tumor, culturing a GSC derived from GBM tissue derived from a GBM tumor, contacting aliquots thereof with individual compounds selected from a panel of compounds, and identifying two or more of the selected compounds that cause more than a threshold level of cell death in the aliquots, thereby identifying the compounds.

Claim (Index 85):
The method of  claim 77 , wherein at least one of the one or more combinations comprises at least one anti-neoplastic/chemotherapeutic compound.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 86.0
- Lexical Diversity: 2.71667
- Patent Class: 506.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15026225', '13617486', '14852378', '15186188', '13996114']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5429594204022048
- 35 USC 102 Novelty (BERT): 0.51479347183686
- Combined Prediction Score: 0.5401428255456703
- Mean Citation Score: 174.008272
- Max Citation Score: 196.14246
- Similarity Product: 102.75921644410732

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test